Chapter Assessing the Performance of Personal Protective Equipment1 (Record no. 38063)

MARC details
000 -LEADER
fixed length control field 02378naaaa2200277uu 4500
001 - CONTROL NUMBER
control field https://directory.doabooks.org/handle/20.500.12854/70381
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 65778
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.5772/65778
Terms of availability doi
041 0# - LANGUAGE CODE
Language code of text/sound track or separate title English
042 ## - AUTHENTICATION CODE
Authentication code dc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMG
Source bicssc
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kechagiadakis, Georgios
Relationship auth
245 10 - TITLE STATEMENT
Title Chapter Assessing the Performance of Personal Protective Equipment1
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. InTechOpen
Date of publication, distribution, etc. 2017
506 0# - RESTRICTIONS ON ACCESS NOTE
Terms governing access Open Access
Source of term star
Standardized terminology for access restriction Unrestricted online access
520 ## - SUMMARY, ETC.
Summary, etc. Schistosomiasis is the second most prevalent parasitic disease in the world. Currently, the treatment of this disease relies on a single drug, praziquantel, and due to the identification of resistant parasites, the development of new drugs is urged. The demand for the development of robust high‐throughput parasite screening techniques is increasing as drug discovery research in schistosomiasis gains significance. Here, we review the most common methods used for compound screening in the parasites life stages and also summarize some of the methods that have been recently developed. In addition, we reviewed the methods most commonly implemented to search for promising targets and how they have been used to validate new targets against the parasite Schistosoma mansoni. We also review some promising targets in this parasite and show the main approaches and the major advances that have been achieved by those studies. Moreover, we share our experiences in schistosomiasis drug discovery attained with our S. mansoni drug screening platform establishment.
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction Creative Commons
Use and reproduction rights https://creativecommons.org/licenses/by/3.0/
Source of term cc
-- https://creativecommons.org/licenses/by/3.0/
546 ## - LANGUAGE NOTE
Language note English
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology
Source of heading or term bicssc
653 ## - INDEX TERM--UNCONTROLLED
Uncontrolled term Schistosoma mansoni, drug screening, histone‐modifying enzymes, protein kinases, inhibitors, RNA interference
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pirlot, Marc
Relationship auth
773 10 - HOST ITEM ENTRY
Host Biblionumber OAPEN Library ID: ONIX_20210602_10.5772/65778_336
Control subfield nnaa
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://library.oapen.org/bitstream/20.500.12657/49222/1/54088.pdf">https://library.oapen.org/bitstream/20.500.12657/49222/1/54088.pdf</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://library.oapen.org/bitstream/20.500.12657/49222/1/54088.pdf">https://library.oapen.org/bitstream/20.500.12657/49222/1/54088.pdf</a>
Access status 0
Public note DOAB: download the publication
856 40 - ELECTRONIC LOCATION AND ACCESS
Host name www.oapen.org
Uniform Resource Identifier <a href="https://directory.doabooks.org/handle/20.500.12854/70381">https://directory.doabooks.org/handle/20.500.12854/70381</a>
Access status 0
Public note DOAB: description of the publication

No items available.